Molecular analysis of the interaction of Bordetella pertussis adenylyl cyclase with fluorescent nucleotides

Molecular Pharmacology

Volumn 72, Issue 3, 2007, Pages 526-535

  Göttle, Martin ^a   Dove, Stefan ^a   Steindel, Phillip ^a   Shen, Yuequan ^c   Tang, Wei Jen ^b   Geduhn, Jens ^a   König, Burkhard ^a   Seifert, Roland ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF CHICAGO   (United States)

^c NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' N METHYLANTHRANILOYL; ADENYLATE CYCLASE; NUCLEOTIDE; UNCLASSIFIED DRUG;

ARTICLE; BACILLUS ANTHRACIS; BORDETELLA PERTUSSIS; CATALYSIS; ENZYME ACTIVITY; FLUORESCENCE; FLUORESCENCE RESONANCE ENERGY TRANSFER; MAMMAL; MOLECULAR BIOLOGY; PRIORITY JOURNAL;

EID: 34548315751     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.034413     Document Type: Article

References (28)

1. Ahuja N, Kumar P, and Bhatnagar R (2004) The adenylate cyclase toxins. Crit Rev Microbiol 30:187-196.
2. Boyd AP, Ross PJ, Conroy H, Mahon N, Lavelle EC, and Mills KH (2005) Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death. J Immunol 175:730-738.
3. Carbonetti NH, Artamonova GV, Andreasen C and Bushar N (2005) Pertussis toxin and adenylate cyclase toxin provide a one-two punch for establishment of Bordetella pertussis infection of the respiratory tract. Infect Immun 73:2698-2703 .
4. Clark M, Cramer RD III, and Van Opdenbosch N (1989) Validation of the general purpose Tripos 5.2 force field. J Comp Chem Soc 10:982-1012.
5. Confer DL and Eaton JW (1982) Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science 217:948-950.
6. Cornell WD, Cieplak P, Bayly CI, Gould IR, Merz KMJ, Ferguson DM, Spellmeyer DC, Fox T, Caldwell JW, and Kollman PA (1995) A second generation force field for the simulation of proteins and nucleic acids. J Am Chem 117:5179-5197.
7. Ghose AK, Viswanadhan VN, and Wendoloski JJ (1998) Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: an analysis of ALOGP and CLOGP methods. J Phys Chem 102:3762-3772.
8. Gille A, Lushington GH, Mou TC, Doughty MB, Johnson RA, and Seifert R (2004) Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides. J Biol Chem 279:19955-19969.
9. Gille A and Seifert R (2003) 2′(3′)-O-(N- methylanthraniloyl)-substituted GTP analogs: a novel class of potent competitive adenylyl cyclase inhibitors. J Biol Chem 278:12672- 12679.
10. Gilles AM, Munier H, Rose T, Glaser P, Krin E, Danchin A, Pellecuer C, and Barzu O (1990) Intrinsic fluorescence of a truncated Bordetella pertussis adenylate cyclase expressed in Escherichia coli. Biochemistry 29:8126-8130.
11. Guo Q, Shen Y, Lee YS, Gibbs CS, Mrksich M, and Tang WJ (2005) Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin. EMBO J 24:3190-3201.
12. Heiden W, Moeckel G, and Brickmann J (1993) A new approach to analysis and display of local lipophilicity/hydrophilicity mapped on molecular surfaces. J Comput Aided Mol Des 7:503-514.
13. Hewlett EL, Donato GM, and Gray MC (2006) Macrophage cytotoxicity produced by adenylate cyclase toxin from Bordetella pertussis: more than just making cyclic AMP! Mol Microbiol 59:447-459.
14. Hewlett EL, Gordon VM, McCaffery JD, Sutherland WM, and Gray MC (1989) Adenylate cyclase toxin from Bordetella pertussis. Identification and purification of the holotoxin molecule. J Biol Chem 264:19379- 19384.
15. Hiratsuka T (1983) New ribose-modified fluorescent analogs of adenine and guanine nucleotides available as substrates for various enzymes. Biochim Biophys Acta 742:496-508.
16. Hiratsuka T (2003) Fluorescent and colored trinitrophenylated analogs of ATP and GTP. Eur J Biochem 270:3479-3485.
17. Jameson DM and Eccleston JF (1997) Fluorescent nucleotide analogs: synthesis and applications. Methods Enzymol 278:363-390.
18. Johnson RA and Shoshani I (1990) Inhibition of Bordetella pertussis and Bacillus anthracis adenylyl cyclases by polyadenylate and "P"-site agonists. J Biol Chem 265:19035-19039.
19. Ladant D and Ullmann A (1999) Bordetella pertussis adenylate cyclase: a toxin with multiple talents. Trends Microbiol 7:172-176.
20. Lakowicz JR (1999) Principles of Fluorescence Spectroscopy. Kluwer Academic/Plenum, New York.
21. Mock M and Ullmann A (1993) Calmodulin-activated bacterial adenylate cyclases as virulence factors. Trends Microbiol 1:187-192.
22. Mou TC, Gille A, Fancy DA, Seifert R, and Sprang SR (2005) Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2′(3′)-O-(N-methylanthraniloyl)-guanosine 5′-triphosphate. J Biol Chem 280:7253-7261.
23. Mou TC, Gille A, Suryanarayana S, Richter M, Seifert R, and Sprang SR (2006) Broad specificity of mammalian adenylyl cyclase for interaction with 2′,3′-substituted purine- and pyrimidine nucleotide inhibitors. Mol Pharmacol 70:878-886.
24. Rottlaender D, Matthes J, Vatner SF, Seifert R, and Herzig S (2007) Functional adenylyl cyclase inhibition in murine cardiomyocytes by 2′(3′)-O-(N-methylanthraniloyl)-guanosine 5′-[γ-thio]triphosphate. J Pharmacol Exp Ther 321:608-615.
25. Sarfati RS, Kansal VK, Munier H, Glaser P, Gilles AM, Labruyere E, Mock M, Danchin A, and Barzu O (1990) Binding of 3′-anthraniloyl-2′- deoxy-ATP to calmodulin-activated adenylate cyclase from Bordetella pertussis and Bacillus anthracis. J Biol Chem 265:18902-18906.
26. Shen Y, Lee YS, Soelaiman S, Bergson P, Lu D, Chen A, Beckingham K, Grabarek Z, Mrksich M, and Tang WJ (2002) Physiological calcium concentrations regulate calmodulin binding and catalysis of adenylyl cyclase exotoxins. EMBO J 21:6721-6732.
27. Shen Y, Zhukovskaya NL, Zimmer MI, Soelaiman S, Bergson P, Wang CR, Gibbs CS, and Tang WJ (2004) Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection. Proc Natl Acad Sci U S A 101:3242-3247.
28. Soelaiman S, Wei BQ, Bergson P, Lee YS, Shen Y, Mrksich M, Shoichet BK, and Tang WJ (2003) Structure-based inhibitor discovery against adenylyl cyclase toxins from pathogenic bacteria that cause anthrax and whooping cough. J Biol Chem 278:25990-25997.